Protein-surface-designed molecules activate PPARs
A generative model designed molecules from the three-dimensional surfaces of PPAR proteins: synthesized in the laboratory, they increased activity and were tested by Roche. They demonstrate the method and are not intended for commercial development; the tests do not establish safety or efficacy in humans.
Technology: Protein-surface-guided generative AI
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: ETH chemists synthesized the AI-designed molecules in the lab, and Roche ran a variety of tests showing they are stable and non-toxic.
- Still unknown: The article does not state limitations, the molecules were not developed toward market, and the tests do not establish safety or efficacy in humans.
- AI role: A generative model designed molecules from scratch matched to a protein's three-dimensional surface, without human intervention.
Evidence sources: https://ethz.ch/en/news-and-events/eth-news/news/2024/04/ai-designs-new-drugs-based-on-protein-structures.html
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 121 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.